These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
    Author: Binfiglio G, Stefani S, Nicoletti G.
    Journal: Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454.
    Abstract:
    Most members of the Enterobacteriaceae and Pseudomonas aeruginosa possess an inducible chromosomal class I beta-lactamase. Bacterial strains which produce high levels of beta-lactamase constitutively can be isolated from infections; these derepressed mutants are responsible for resistance to third-generation cephalosporins and ureidopenicillins. Minimum inhibitory concentrations of cefpirome, a fourth-generation cephalosporin, and other beta-lactam antibiotics were determined for a series of mutants of Citrobacter freundii, Enterobacter cloacae, Morganella morganii, Proteus vulgaris and Serratia marcescens with inducible stably derepressed or basal expression of chromosomal class I beta-lactamases. All the antibiotics tested were almost equally active against beta-lactamase-inducible organisms and their basal mutants. Imipenem and cefpirome showed better activity against derepressed mutants than third-generation cephalosporins and ureidopenicillins.
    [Abstract] [Full Text] [Related] [New Search]